Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

patients * patients 143

FK

esylate) in HIV-infected
nitoring in HIV-infected
ical treatment failure in
eatments for HIV/AIDS
py among HIV-infected
cal reality: Doctors' and
n the treatment of HIV
mber of deaths among
advanced HIV-infected
ternative therapy use in
urnover in HIV-infected
n body cell mass in HIV
-related quality of life in
ition therapies for HIV+
nutritional evaluation in
ight and composition in
didiasis in HIV-infected
I and infections in AIDS
cells from HIV infected
y parameters in female
of use among HIV clinic
rmulation in Indian HIV
se among HIV-infected
lives of HIV+ and AIDS
drugs in HIV-1 infected
e program for HIV/AIDS
bility and CD4 levels in
native model of care for
epatitis B in HIV positive
creening in HIV-infected
ia/Home care of AIDS
dical care for HIV/AIDS
h care utilization by HIV
hanging patterns of HIV
aluation of HIV-infected
easures/Adherence of
y in Paris, France/Outnt hospital care of AIDS
and HIV-negative adult
lications in HIV infected
es used by HIV positive
post test counselling in
itiation of health care in
edical attention: Are the
ons (NI) in HIV infected
sfusion HIV (PT-HIV) in
ting and counselling on
sistance of HIV reactive
sion rate in inner-city in/HIV infection study on
HIV infected minorities
mitted diseases (STD)
with regard to HIV/AIDS
of death in HIV-infected
ression in HIV-infected
hylaxis in HIV-infected
partner referral of STD
on of care to AIDS/HIV
stitutions of psychiatric
MV prophylaxis in AIDS
302 treatment for AIDS
DNA among STD/AIDS
ng imunocompromised
nt of 745 HIV and AIDS
osis in Cuban VIH/AIDS
ing in HIV/AIDS/cancer
ode enlargement in HIV, India/Survival of AIDS
ce of STDs in HIV/AIDS
hanges in HIV-infected
4+ T cell subset in AIDS
ation (AOP) in HIV +ve
evels in HIV-1-infected
trategies to handle HIV
e/Treating tuberculosis

nd quality of life in AIDS
avir/Drug compliance in
life in symptomatic HIV
V) to nelfinavir (NFV) in
h Indian HIV-1 infected

reyword Abstract +
enrolled in a phase III clinical trial 42267
receiving indinavir/Therapeutic d 42272
using IDV-containing triple therap 42275
- Dream and reality/Malawi: Dru 42286
attending selected out-patient cli 445*/42291
'view of health care and treatment 42293: Patterns of use and efficacy data 42303
of an AIDS referral center in Sao 42319
/Double blind placebo controlled t 42326
with HIV: "Snake oil" or panacea? 42327,effect of nutritional intervention/ 42332
with weight loss/Glutamine/antio 42336
infected with HIV/Nutritional stat 42338
warrants enhanced nutrition educ 42341
with HIV infection/Expanded nutr 42349
with HIV-associated weight loss/ 42351
-A retrospective analysis/The po 42355: Analysis according to initial seru 42363
in Argentina/Antioxidants enzym 42368
with AIDS (FPWA)/Effect of dehy 42373
/Complementary therapy (CT): C 42379: A pilot study/Effect of unique her 42385
of the inner city/Alternative thera 42391
/The role of herbal supplementati 42392
in South India/Immunological an 42395
/Development of a community-ba 42401
receiving protease inhibitors in cli 42403
with HIV/HIV pharmaceutical car 42410
/Immunisation against hepatitis B 42418
/Cytomegalovirus screening in HI 42420
from the medical and nursing vie 42423
to control opportunistic infections 69*/42425
in hospital based clinic providing i 42432
management: Consequence of n 42440
on an emergency room/Evaluatio 42441
with AIDS to treatment with antire 42442
care of uninsured HIV+ patients: 42444: An eight-year assessment in an i 42445
in Kenyatta National Hospital (KN 42446
/Surgical complications in HIV inf 42448
in France, between June 1995 an 42451
admitted in two medical wards in 42455
with HIV/AIDS in Guatemala/De 42456
the same?/Ten years in HIV medi 42462
in an Brazilian hospital/Nosocom 42463
receiving autologous and allogeni 42464
and clients in a Nairobi hospital/T 42467
/Hospital/day: An alternative for a 42468
1995-1996/HIV seroconversion 43137
at the "Eva Per6n" Teaching Hos 43153
accessing medical care: An archi 43239
/Evaluation of a European project 43426
care/Development of a follow-up 43464
/Time-dependence of predictors 43468
without AIDS in the era of antiretr 43474
with CD4 cells < 75/mm3: An upd 43481
on the spread of HIV in Nairobi: E 43490
to health center level requires hea 43519
associated with HIV virus infectio 44197? Insights from a cost-effectivene 44242
/A study on Chinese herbal formul 60010
in Tunisia/Detection of papilloma 60012
in Tunisia/Detection of cytomega 60013
at NGO, OPD clinic, Bangalore, I 60054
/Serological technique utility in th 60066
/Palliative care/end of life and cou 60069: Diagnosis by fine-needle aspirati 60073
in Manipur, India/Survival of AID 60078
in the Dominican Republic/Preva 60115
under combination therapy contai 60118
/Correlation between basal HIV-1 60122:A prominent, frequent and multi i 60125
with CD4+ T lymphocytes of 200/ 60132

and their families/Christian psych 60145
among HIV/AIDS clients in a supp 60146
with anemia and MAC infection/H 60149
starting saquinavir/Drug complia 60151
/Homoeopathic approach in impr 60179
on antiviral combination therapy 60181
/Evaluation of the efficacy and tol 60189

sus visceral disease in
treatment of HIV/AIDS
n Ugandan adult AIDS
dult HIV(+)/AIDS naive
tionnaire of HIV+/AIDS
n infection in HIV/AIDS
ntercurrent infections in
s on plasma viral load in
of CNS mass lesions in
AL) fluid of HIV positive
lence of of HIV positive
African-American adult
rotease genotypes in
n French HIV-1 infected
py in HIV-AIDS infected
teremia in HIV-infected
iller cell activity in AIDS
are for HIV infected IDU
e utilization in HIV/AIDS
reatment-naive HIV-1
pine rescue therapy for
of aphtous ulcers in HIV
V retinitis in Swiss AIDS
tors (PI) in HIV infected
elipase therapy in HIV+
iretroviral (ARV)-naive
al status in hospitalized
onger time to relapse in
y: A cohort study of 626
rculosis in HIV infected
ns in HIV infected/AIDS
Characteristics of AIDS
d Japanese hemophilic
on therapy? The role of
s by HIV-1 seropositive
cal meningitis in 2 HIV+
neuropathic pain in HIV
service for HIV-infected
meone's attention/AIDS
ath implantation in HIV+
y in highly experienced
etween physicians' and
volution of env-V3 in six
-Hodgkin's lymphoma
zation in HIV-1 infected
ses in body cell mass of
on adherence issues in
nel surveillance in STD
CNS lymphoma in HIV
e higher viral loads than
s in HIV-1+ and HIV-1 -carnitine levels in AIDS
s sarcoma in two AIDS
rofiles of HIV positive
f HHV8 prevalence in
and ex-homeless AIDS
erculosis between HIV
sions in HIV+ and AIDS
cancers in HIV infected
or support group helps
ed survival in HIV/AIDS
ease inhibitors in HIV+
AIDS mortality in adult
udy of HIV antibodies in
ral therapy (HAART) in
equence of HIV from
plasma and saliva from
ation in HIV-co-infected
atisfaction of HIV/AIDS
c abnormalities in HIV+
hospitalization to AIDS
Ith/Economic profile of
ne HAART therapy: 21
a cohort of HIV-positive
roviral treatment in Irish

cribed marijuana use in
nemia in HIV-1 infected
V-1/HTLV-II co-infected
actic care for HIV/AIDS
azards for HIV infected

Keyword Abstra
with active CMV disease/Predicti
/AIDS Centre of West Bohemia a
with cryptococcal meningitis/A pil
/CD4 marker of immune restorati
/Evaluation of selected questions
using herb medicine (3G)/Contro
with HIV-1 disease/Incidence, ty
with HIV-1 disease/Influence of t
with AIDS/Use of thallium-201 S
with pulmonary infections/Cytolo
with cryptococcal infections at Mp
with HIV disease/The "do not res
with HIV-1 symptomatic primary i
/HHV-8 sequence variability in Fr
/Protease inhibitor (PI) change wi
/A prospective study of non-myco
/Interleukin (IL-2 deficiency aggra
/Attitude of French GPs towards c
at a Veterans Affairs Medical Cen
with 50-250 CD4 cells/mm3/Sub
failing protease inhibitor based th
/Pentoxifylline for the treatment of
/Pharmacoeconomic analysis of f
over the age of 50/The use of prot
with chronic diarrhea/Preliminary
with CD4 counts of 20-300/mm3 /
with HIV infection/Nutricional stat
with CMV retinitis/Protease inhibi
(Bordeaux, France, 1992-1997)/
/Clinical characteristics and survi
/Incidence of nosocomial infectio
referred to home care service in
/Natural protease mutations obse
' self disclosure and trust in physic
/Acquisition of explicit and implicit
/Asymptomatic cryptococcal men
/Efficacy of a standardized acupu
/Post-insertion complications of
/a call to attract someone's attenti
/CMV disease and port-a-cath im
/Hour drug therapy including nelfi
' advises about adherence to antiv
iatrogenically infected with an HI
(AIDS-NHL pts)/Effect on virologi
/Plasma levels of pro-inflammator
with HIV associated wasting after
requiring in-patient HIV care/Med
1992-1997/Sentinel surveillance?/Epstein-Barr virus (EBV) PCR o
with visceral KS/Patients with cut
/Study of lymphocyte subsets in r
with advanced HIV disease from t
treated with HAART including anti
in a hospital based chiropractic cli
presenting at a STD department/
with combined antiretroviral thera
in a Spanish region with a high inc
/Human papilloma virus (HPV) le
at an urban teaching hospital/No
increase knowledge and meet he
treated with aggressive combinati
/Decreased healthcare utilization
in the last 3 years: Decreasing tre
with non-Hodgkin's lymphoma (N
with HIV and tuberculosis (TB)/Di
with HIV infection in Hiroshima ar
with HIV infection/Characteristic
/Lack of activity of the protease in
receiving care at Bamrasnaradur
with Pneumocystis carinii pneum
in Brazil/Therapeutical domicile a
beneficiary of therapeutical domi
from Cook County Hospital, Chic

/Cytomegalovirus (CMV) DNA de
/Effect of antiretroviral treatment i
with HIV-associated upper gastro: A role for HIV-1 in cryoglobulin fo
with or without predominantly sen
at Wellesley Central Hospital/Chi
to continue medical treatment/Ha

ct---
60191
60194
60231
60235
60248
60259
60263
60264
60275
60281
60282
60287
60316
60318
60321
60322
60325
60338
60341
60358
60365
60371
60374
60388
60391
60397
60399
60405
60411
60437
60438
60439
60444
60447
60450
60452
60453
60462
60477
60478
60480
60481
60483
60487
60488
60489
60490
60492
60496
60499
60502
60508
60510
60512
60519
60528
60544
60560
60567
60574
60576
60578
60580
60581
60582
60586
60587
60598
60599
60601
60616
60617
60619

60622
60624
60634
60655
60660
60661
60666